Status:
NOT_YET_RECRUITING
Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
Atrium Health Wake Forest Baptist
Conditions:
Cancer
Frail
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The study purpose is to gain a better understanding of the needs of adults aged 65 and older while they are receiving chemotherapy by measuring their resilience and tailor care plans based on their in...
Detailed Description
This is a prospective single-arm intervention trial of patients aged 65 or older with an active cancer diagnosis who are planned to receive chemotherapy and are eFI (Electronic Health Record (EHR)-bas...
Eligibility Criteria
Inclusion
- Patients with cancer:
- Ability to understand and willingness to sign an IRB-approved informed consent
- Age ≥ 65 years at the time of enrollment.
- Planned to initiate an outpatient chemotherapy regimen for cancer treatment (any type or stage), either as an initial therapy or as a new line of therapy, with curative or palliative intent.
- eFI pre-frail or frail status (available in EHR) within 30 days before enrollment.
- Ability to read and understand the English language
- Providers:
- Treating medical oncologist of at least one patient participant who enrolled on to the study and completed baseline assessment.
Exclusion
- Patients:
- Documented physical or psychological comorbidity that would limit participant's ability to understand or comply with study procedures for the entire length of the study per the enrolling investigator.
- Chemotherapy planned at a facility outside the Atrium Health system.
- Currently receiving chemotherapy
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT07175376
Start Date
January 1 2026
End Date
May 1 2027
Last Update
September 19 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Levine Cancer Institute
Charlotte, North Carolina, United States, 28204
2
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States, 27157